Rads S.L., Inc.
Country not established
- Devices
- 3
What Rads S.L., Inc. makes
Rads S.L., Inc. manufactures IR-192 implants, a type of radioactive seed used primarily for brachytherapy in cancer treatment. These implants are designed for interstitial radiation therapy, delivering precise doses to targeted tissue.
The company’s portfolio is regulated under Class II devices in the US, with products listed via the FDA’s 510(k) pathway. The implants are tracked in the FDA’s 510(k) registry. The manufacturer is based in the United States.
Catalogue
Ir-192 Implant Ref K903465
Regimes: 510(k) Registry: 510(k)Ir-192 Implant Ref K844248
Regimes: 510(k) Registry: 510(k)Ir-192 Implant Ref K874895
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Rads S.L., Inc. have in the registry?
The registry currently lists 3 devices for Rads S.L., Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Rads S.L., Inc.'s devices?
Among its 3 most recently registered devices, Rads S.L., Inc. has devices listed in FDA 510(k) (3 devices).
What risk classes do Rads S.L., Inc.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Rads S.L., Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Rads S.L., Inc. in the registry?
The most recently registered devices listed for Rads S.L., Inc. include IR-192 IMPLANT.